Healthcare Services

Viral Vector Affinity Resin Market Revenue Growth Expected to Reach $1.3 Billion by 2030 with 15.9% CAGR

April 7, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Viral Vector Affinity Resin Market Across 2026–2030?

The viral vector affinity resin market has seen swift growth in recent years. Its value is projected to rise from $0.62 billion in 2025 to $0.72 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.2%. Historically, this growth can be ascribed to several factors, including the widening of viral vector research activities, the increasing adoption of chromatography in bioprocessing, the proliferation of gene therapy development programs, a heightened need for scalable purification solutions, and advances in resin manufacturing technologies.

The viral vector affinity resin market size is projected to experience swift expansion in the coming years. This sector is anticipated to reach $1.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.9%. The projected increase during this period stems from factors such as the rising commercialization of gene therapies, an escalating need for high-throughput purification platforms, the broadening of vaccine development pipelines, a heightened emphasis on cost-effective downstream processing, and the greater uptake of customized affinity resins. Key trends anticipated within the forecast period encompass the increasing integration of high-capacity affinity resins, a growing requirement for AAV and lentiviral purification solutions, the expanding utilization of single-use chromatography systems, advancements in ligand-specific resin development, and an intensified focus on high-purity viral vector processing.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30426&type=smp

Which Market Drivers Are Supporting The Expansion Of The Viral Vector Affinity Resin Market?

The increasing use of gene-based therapeutics is projected to stimulate the expansion of the viral vector affinity resin market in the future. Gene-based therapeutics represent advanced medical treatments that employ DNA, RNA, or viral vectors to alter or regulate gene expression within a patient’s cells. The adoption of these therapies is accelerating due to advancements in delivery systems, which facilitate the safe, efficient, and targeted transport of genetic material into cells. Viral vector affinity resin supports the greater adoption of gene-based therapeutics by offering highly pure and scalable purification solutions, making them essential for viral vector manufacturing. These resins minimize downstream processing difficulties by effectively separating viral vectors from impurities, thereby boosting production efficiency and enabling broader clinical and commercial applications. For instance, in December 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved six gene therapy products in 2023, a rise from five approvals in 2022. Consequently, the increasing adoption of gene-based therapeutics is fueling the growth of the viral vector affinity resin market.

What Segmentation Levels Are Considered In The Viral Vector Affinity Resin Market?

The viral vector affinity resin market covered in this report is segmented –

1) By Product Type: Adenoviral Vector Affinity Resin, Lentiviral Vector Affinity Resin, Adeno-Associated Viral (AAV) Vector Affinity Resin, Retroviral Vector Affinity Resin, Other Product Types

2) By Application: Gene Therapy, Vaccine Development, Cell Therapy, Other Applications

3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations

Subsegments:

1) By Adenoviral Vector Affinity Resin: Cell Lysis-Based Adenoviral Vector Affinity Resin, Chromatography-Based Adenoviral Vector Affinity Resin, High-Capacity Adenoviral Vector Affinity Resin, Prepacked Column Adenoviral Vector Affinity Resin

2) By Lentiviral Vector Affinity Resin: High-Purity Lentiviral Vector Affinity Resin, Column-Based Lentiviral Vector Affinity Resin, Membrane Chromatography Lentiviral Vector Affinity Resin, Single-Use Lentiviral Vector Affinity Resin

3) By Adeno-Associated Viral Vector Affinity Resin: Serotype-Specific Adeno-Associated Viral Vector Affinity Resin, High-Capacity Adeno-Associated Viral Vector Affinity Resin, Prepacked Column Adeno-Associated Viral Vector Affinity Resin, Ligand-Based Adeno-Associated Viral Vector Affinity Resin

4) By Retroviral Vector Affinity Resin: High-Selectivity Retroviral Vector Affinity Resin, Column-Based Retroviral Vector Affinity Resin, Membrane-Based Retroviral Vector Affinity Resin, Prepacked Retroviral Vector Affinity Resin

5) By Other Product Types: Hybrid Viral Vector Affinity Resin, Multimodal Viral Vector Affinity Resin, Recombinant Ligand Affinity Resin, Customized Viral Vector Affinity Resin

Which Leading Firms Are Contributing To The Growth Of The Viral Vector Affinity Resin Market?

Major companies operating in the viral vector affinity resin market are Thermo Fisher Scientific, GE Healthcare Technologies Inc., Repligen Corporation, Creative Biolabs, JNC Corporation, Aptamer Group, ChromaGenix Inc., Cytiva (Danaher Corporation), Merck KGaA, Sartorius AG, Purolite Life Sciences, Tosoh Bioscience, Bio-Rad Laboratories, Avantor Inc., Pall Corporation, Takara Bio Inc., Cube Biotech, Agilent Technologies, Promega Corporation, Kaneka Corporation

Read the full viral vector affinity resin market report here:

https://www.thebusinessresearchcompany.com/report/global-viral-vector-affinity-resin-market-report

How Is The Viral Vector Affinity Resin Market Distributed Across Key Geographic Regions?

North America was the largest region in the viral vector affinity resin market in 2025. The regions covered in the viral vector affinity resin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Viral Vector Affinity Resin Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30426&type=smp

Browse Through More Reports Similar to the Global Viral Vector Affinity Resin Market 2026, By The Business Research Company

Oral Expectorant Global Market Report

https://www.thebusinessresearchcompany.com/report/oral-expectorant-global-market-report

Viral And Non Viral Vector Manufacturing Global Market Report

https://www.thebusinessresearchcompany.com/report/viral-and-non-viral-vector-manufacturing-global-market-report

Protein A Resin Global Market Report

https://www.thebusinessresearchcompany.com/report/protein-a-resin-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795